Next Article in Journal
Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
Previous Article in Journal
Hearing Loss in Beta-Thalassemia: Systematic Review
 
 
Article
Peer-Review Record

Which Parameter Influences Local Disease-Free Survival after Radiation Therapy Due to Osteolytic Metastasis? A Retrospective Study with Pre- and Post-Radiation Therapy MRI including Diffusion-Weighted Images

J. Clin. Med. 2022, 11(1), 106; https://doi.org/10.3390/jcm11010106
by Jiyeong Lee, Young Cheol Yoon *, Ji Hyun Lee and Hyun Su Kim
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2022, 11(1), 106; https://doi.org/10.3390/jcm11010106
Submission received: 20 October 2021 / Revised: 10 December 2021 / Accepted: 22 December 2021 / Published: 25 December 2021
(This article belongs to the Section Oncology)

Round 1

Reviewer 1 Report

I thank the authors and the editor for this very interesting manuscript. 
However, I think the English should be read by a native-speaking.
The authors note the major limitations of this preliminary work. In particular, the very small size of the population and the heterogeneity of the patients and treatments. The greatest limitation is the absence of a validation cohort. 
Moreover, I think that it is difficult with such a small number of patients to carry out statistical tests of survival. In my opinion, the authors should limit themselves to univariate non-parametric statistical tests.

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The authors submitted the manuscript titled with” Which Parameter Influences the Local Disease Free Survival After Radiation Therapy Due to Osteolytic Metastasis? A Retrospective Study with Pre- and Post-radiation Therapy MRI Including Diffusion-weighted Images. Although the manuscript is well-written and well discussed, the novelty is limited due to a small cohort population containing with the heterogeneity of tumor types and osteolytic sites, as shown in the limitation.

There are several reasons to be clarified.

 

  1. To serve as a prognostic predictor, the change of interested parameters 6M after treatment seems to be outdated.
  2. Does the osteolytic site matter? Pelvic bone is almost half of the studied sites. Can these be categorized into pelvic or non-pelvic bone?
  3. Owing to small number, the result may be immature.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop